AZD8683 Single Ascending Dose Study

NCT00979849 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

130

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy Volunteers

Interventions

DRUG: AZD8683
DRUG: Placebo

Sponsor

AstraZeneca